ViroCell Biologics
PrivateLast Round
Convertible Debt
Aug 14, 2024
Company Overview
ViroCell Biologics is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) focused on the design, optimization, and GMP manufacturing of lentiviral and retroviral vectors for cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViroCell Biologics Comparables
Compare ViroCell Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vector BioMed, Inc. | 93% | |
| Genezen | 89% | |
| VIVEbiotech | 89% | |
ViroCell Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Aug 14, 2024 | ||||
| Seed | Apr 28, 2021 |
Key People
Founding team and executive leadership
ViroCell Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Disruptive Capital | Seed |
| Truell Conservation Foundation | Seed |
| First Light Asset Management | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors increased 536% MoM, reaching 8.9K.
- Mar 24, 2025
Monthly visitors increased 42% MoM.
ViroCell Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ViroCell Biologics's valuation, stock price, and market status.